Novanta Inc. NOVT
143.93
2.40
1.70%
as of 25 Sep
- Market cap
- $5.4B
- P/E
- 90.6×
Follow NOVT
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
102.04 | 84.36 | 80.95 | 68.13 |
+8 more quarters Free account |
P/S ratio |
6.46 | 4.75 | 4.44 | 3.75 | |
P/FCF ratio |
60.99 | 75.42 | 89.90 | 33.31 | |
P/Operating CF |
102.46 | 92.52 | 494.46 | 424.03 | |
P/B ratio |
4.12 | 3.64 | 3.31 | 4.49 | |
Price to Tangible BV |
8.17 | 9.60 | 8.96 | 0.00 | |
EV/Sales |
5.99 | 4.60 | 4.31 | 4.13 | |
EV/EBITDA |
40.06 | 30.51 | 27.08 | 25.56 | |
EV/Operating CF |
46.06 | 55.10 | 65.94 | 33.94 | |
EV/FCF |
56.51 | 73.09 | 87.21 | 36.66 | |
Quick Ratio |
3.70 | 2.59 | 2.71 | 1.44 | |
Current Ratio |
4.57 | 3.56 | 3.69 | 2.51 | |
Net Debt/EBITDA |
(14.95) | (3.53) | (3.10) | 9.64 | |
Debt/Assets |
10.73% | 13.42% | 13.88% | 29.97% | |
Debt/Equity |
0.14 | 0.18 | 0.19 | 0.56 | |
Asset Turnover |
0.56 | 0.63 | 0.61 | 0.66 | |
Operating CF/Net income |
5.18 | 2.45 | 0.50 | 0.80 | |
Capex/Depreciation |
(0.51) | (0.27) | (0.54) | (0.27) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
9.02% | 9.02% | 8.85% | 9.72% | |
Selling, General and Administrative Expense of Revenue |
22.56% | 21.11% | 19.97% | 20.73% | |
Intangible Assets out of Total Assets |
0.37 | 0.45 | 0.46 | 0.56 | |
Share Based Compensation of Revenue |
3.70% | 3.80% | 3.19% | 2.70% | |
Graham Net Nets |
0.09 | 0.06 | 0.07 | (0.07) | |
Graham Number |
37.55 | 31.96 | 34.47 | 27.15 | |
Earnings Yield |
0.98% | 1.19% | 1.24% | 1.47% | |
Free Cash Flow Yield |
1.64% | 1.33% | 1.11% | 3.00% | |
Revenue per Share |
6.48 | 6.37 | 7.06 | 6.89 | |
Operating CF per Share |
1.58 | 1.28 | 0.24 | 0.24 | |
Capex per Share |
(0.18) | (0.09) | (0.25) | (0.12) | |
Free Cash Flow per Share |
1.40 | 1.18 | (0.01) | 0.12 | |
Cash per Share |
17.52 | 9.62 | 10.41 | 2.48 | |
Shareholders Equity per Share |
39.42 | 32.43 | 35.92 | 22.28 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
39.42 | 32.43 | 35.92 | 22.28 | |
Free Cash Flow |
57.47 | 47.81 | (0.40) | 4.21 | |
Working Capital |
877.66 | 566.01 | 570.23 | 281.56 | |
Capital Expenditures |
(7.47) | (3.79) | (9.21) | (4.28) | |
Net Current Asset Value |
600.43 | 298.78 | 289.78 | (235.92) | |
EV/EBIT |
66.80 | 51.92 | 44.93 | 41.34 | |
Capex to Sales |
0.03 | 0.01 | 0.04 | 0.02 | |
Net Profit Margin |
4.72% | 8.19% | 6.76% | 4.30% | |
Price to Operating Income |
72.10 | 53.57 | 46.31 | 37.57 | |
| Other line items | |||||
Average Receivables |
180.45 | 176.36 | 176.68 | 178.83 | |
Average Payables |
93.23 | 89.36 | 85.88 | 84.47 | |
Average Inventory |
180.39 | 169.29 | 166.45 | 167.00 | |
Average Assets |
1,825.32 | 1,592.26 | 1,597.81 | 1,462.32 | |
Average Common Equity |
1,208.95 | 1,040.39 | 1,029.99 | 771.84 |
Columns are period end dates